India · Delayed Price · Currency is INR MedPlus Health Services Statistics
Total Valuation
NSE:MEDPLUS has a market cap or net worth of INR 71.85 billion. The enterprise value is 81.76 billion.
| Market Cap | 71.85B |
| Enterprise Value | 81.76B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:MEDPLUS has 120.14 million shares outstanding. The number of shares has decreased by -0.23% in one year.
| Current Share Class | 120.14M |
| Shares Outstanding | 120.14M |
| Shares Change (YoY) | -0.23% |
| Shares Change (QoQ) | -1.16% |
| Owned by Insiders (%) | 13.29% |
| Owned by Institutions (%) | 45.35% |
| Float | 71.24M |
Valuation Ratios
The trailing PE ratio is 33.92 and the forward PE ratio is 33.34. NSE:MEDPLUS's PEG ratio is 1.75.
| PE Ratio | 33.92 |
| Forward PE | 33.34 |
| PS Ratio | 0.95 |
| PB Ratio | 3.47 |
| P/TBV Ratio | 3.56 |
| P/FCF Ratio | 38.89 |
| P/OCF Ratio | 20.98 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.53, with an EV/FCF ratio of 44.25.
| EV / Earnings | 38.75 |
| EV / Sales | 1.08 |
| EV / EBITDA | 12.53 |
| EV / EBIT | 23.64 |
| EV / FCF | 44.25 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.75.
| Current Ratio | 2.83 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 2.37 |
| Debt / FCF | 8.38 |
| Interest Coverage | 2.58 |
Financial Efficiency
Return on equity (ROE) is 10.79% and return on invested capital (ROIC) is 9.40%.
| Return on Equity (ROE) | 10.79% |
| Return on Assets (ROA) | 5.56% |
| Return on Invested Capital (ROIC) | 9.40% |
| Return on Capital Employed (ROCE) | 10.09% |
| Weighted Average Cost of Capital (WACC) | 6.80% |
| Revenue Per Employee | 2.63M |
| Profits Per Employee | 73,080 |
| Employee Count | 28,872 |
| Asset Turnover | 1.95 |
| Inventory Turnover | 4.05 |
Taxes
In the past 12 months, NSE:MEDPLUS has paid 546.56 million in taxes.
| Income Tax | 546.56M |
| Effective Tax Rate | 20.58% |
Stock Price Statistics
The stock price has decreased by -20.25% in the last 52 weeks. The beta is 0.46, so NSE:MEDPLUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -20.25% |
| 50-Day Moving Average | 647.26 |
| 200-Day Moving Average | 783.64 |
| Relative Strength Index (RSI) | 34.28 |
| Average Volume (20 Days) | 114,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MEDPLUS had revenue of INR 75.95 billion and earned 2.11 billion in profits. Earnings per share was 17.63.
| Revenue | 75.95B |
| Gross Profit | 19.16B |
| Operating Income | 3.46B |
| Pretax Income | 2.66B |
| Net Income | 2.11B |
| EBITDA | 4.27B |
| EBIT | 3.46B |
| Earnings Per Share (EPS) | 17.63 |
Balance Sheet
The company has 5.57 billion in cash and 15.49 billion in debt, with a net cash position of -9.92 billion or -82.54 per share.
| Cash & Cash Equivalents | 5.57B |
| Total Debt | 15.49B |
| Net Cash | -9.92B |
| Net Cash Per Share | -82.54 |
| Equity (Book Value) | 20.68B |
| Book Value Per Share | 174.46 |
| Working Capital | 14.10B |
Cash Flow
In the last 12 months, operating cash flow was 3.42 billion and capital expenditures -1.58 billion, giving a free cash flow of 1.85 billion.
| Operating Cash Flow | 3.42B |
| Capital Expenditures | -1.58B |
| Depreciation & Amortization | 812.14M |
| Net Borrowing | -1.58B |
| Free Cash Flow | 1.85B |
| FCF Per Share | 15.38 |
Margins
Gross margin is 25.23%, with operating and profit margins of 4.55% and 2.78%.
| Gross Margin | 25.23% |
| Operating Margin | 4.55% |
| Pretax Margin | 3.50% |
| Profit Margin | 2.78% |
| EBITDA Margin | 5.62% |
| EBIT Margin | 4.55% |
| FCF Margin | 2.43% |
Dividends & Yields
NSE:MEDPLUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.23% |
| Shareholder Yield | 0.23% |
| Earnings Yield | 2.95% |
| FCF Yield | 2.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:MEDPLUS is 951.86, which is 59.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 951.86 |
| Price Target Difference | 59.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 14.76% |
| EPS Growth Forecast (3Y) | 4.71% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |